See All News - tctmd.com

News

News Conference News TCT 2013

Debate Continues on Use of Heart Teams for High-Risk Patients with Heart Valve Disease

October 28, 2013

News Conference News TCT 2013

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

October 28, 2013

News Conference News TCT 2013

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

October 28, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

News Conference News TCT 2013

Preliminary Data Show Potential of Renal Denervation in Several Settings

October 28, 2013

News Industry News

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

October 28, 2013

News Industry News

Philips and RealView Imaging conclude world’s first study to evaluate live 3D holographic imaging in interventional cardiology

October 28, 2013

News Industry News

Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next-generation bioresorbable stent at ‘TCT 2013’ annual scientific meeting

October 28, 2013

News Conference News TCT 2013

Cre8, BioFreedom Polymer-Free DES Show Promise

October 28, 2013

News Industry News

META-ANALYSIS DEMONSTRATES REDUCTION IN MORTALITY WITH PCI COMPARED TO MEDICAL THERAPY IN STABLE PATIENTS SELECTED ON THE BASIS OF ISCHEMIA

October 28, 2013

Advertisement

News

Debate Continues on Use of Heart Teams for High-Risk Patients with Heart Valve Disease

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

Preliminary Data Show Potential of Renal Denervation in Several Settings

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

Philips and RealView Imaging conclude world’s first study to evaluate live 3D holographic imaging in interventional cardiology

Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next-generation bioresorbable stent at ‘TCT 2013’ annual scientific meeting

Cre8, BioFreedom Polymer-Free DES Show Promise

META-ANALYSIS DEMONSTRATES REDUCTION IN MORTALITY WITH PCI COMPARED TO MEDICAL THERAPY IN STABLE PATIENTS SELECTED ON THE BASIS OF ISCHEMIA

Search News

Advertisement

Advertisement

News

Search News

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content